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Manyanticancer drugs activate caspases via themitochondrial apoptosis pathway. Activation of this
pathway triggers a concomitant bioenergetic crisis caused by the release of cytochrome-c (cyt-c).
Cancer cells are able to evade these processes by altering metabolic and caspase activation
pathways. In this study, we provide the first integrated system study of mitochondrial bioenergetics
and apoptosis signalling and examine the role of mitochondrial cyt-c release in these events.
In accordance with single-cell experiments, our model showed that loss of cyt-c decreased
mitochondrial respiration by 95% and depolarised mitochondrial membrane potential DWm from
142 to88mV, with active caspase-3 potentiating this decrease. ATP synthase was reversed under
such conditions, consuming ATP and stabilising DWm. However, the direction and level of ATP
synthase activity showed significant heterogeneity in individual cancer cells, which the model
explained by variations in (i) accessible cyt-c after release and (ii) the cell’s glycolytic capacity. Our
results provide a quantitative and mechanistic explanation for the protective role of enhanced
glucose utilisation for cancer cells to avert the otherwise lethal bioenergetic crisis associated with
apoptosis initiation.
Molecular Systems Biology 7: 470; published online 1 March 2011; doi:10.1038/msb.2011.2
Subject Categories: cellular metabolism; differentiation & death
Keywords: apoptosis; bioenergetics; cancer; ODE; single-cell imaging
This is an open-access article distributed under the terms of the Creative Commons Attribution
Noncommercial Share Alike 3.0 Unported License, which allows readers to alter, transform, or build upon
thearticle and thendistribute the resultingworkunder the sameorsimilar license to thisone. Theworkmust
be attributed back to the original author and commercial use is not permitted without specific permission.
Introduction
Cytochrome-c (cyt-c) is a key component of the mitochondrial
respiratory chain, located in the intermembrane space (IMS)
and responsible for transporting electrons from respiratory
complex III to complex IV. By converting the redox potential
established by glycolysis and the tricarboxylic acid cycle
(TCA) into a proton gradient across the inner mitochondrial
membrane, cyt-c is required to maintain polarisation of the
mitochondrial transmembrane potential (DCm). In turn, DCm
establishes a proton-motive force for the (FoF1-)ATP synthase
to produce ATP (oxidative phosphorylation—OXPHOS;
Mitchell, 1961; Nicholls and Ward, 2000), which preserves
the cycling of Naþ , Ca2þ , Kþ , Cl ions and protons across the
mitochondrial and the plasma membranes to maintain ionic
and osmotic homeostasis and to prevent necrotic cell death
(Nicholls, 1977; Nicholls and Budd, 2000).
To induce cancer cell death, chemotherapeutic agents often
generate conditions such as genotoxic stress that lead to cyt-c
release from the mitochondrial IMS into the cytosol, a process
referred to asmitochondrial outer membrane permeabilisation
(MOMP). This disrupts the mitochondrial respiratory chain
and causes DCm depolarisation, which in turn can result in a
bioenergetic crisis characterised byATP depletion, loss of ionic
homeostasis, increased osmotic pressure and necrotic cell
death (Jurgensmeier et al, 1998; Nicholls and Budd, 2000;
Dussmann et al, 2003a). In addition, cyt-c release is also a
direct transducer of apoptotic signals. Its presence in the
cytosol enables the formation of the apoptosome, a heptameric
complex of the cytosolic apoptotic protease-activating factor-1
and caspase-9 (Liu et al, 1996; Kluck et al, 1997), which
activates effector caspases, in particular caspase-3 (Srinivasula
et al, 1998; Slee et al, 1999).
However, many cancer cells have developed strategies
to survive both consequences of cyt-c release. Some cancer
cells bypass caspase-dependent apoptosis through loss-of-
function mutations or overexpression of caspase inhibitors.
While the molecular mechanisms and systems aspects of
impairment of caspase-dependent cell death are quite well
understood (Deveraux and Reed, 1999; Rehm et al, 2006;
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Huber et al, 2007, 2010), the means by which cancer
cells can survive, despite cyt-c release-induced bioenergetic
crisis, remain more elusive. The complexity of bioenergetic
pathways can barely be captured by traditional studies
that focus on a single metabolite or protein at a time. More-
over, interdependencies between mitochondrial and cellular
bioenergetics and caspase-dependent cell death have been
identified (Matsuyama et al, 2000; Ricci et al, 2003), posing
the need for their coinvestigation in a holistic approach. In
this report, we present the first integrated systems biology
study of mitochondrial bioenergetics and apoptosis and
bridge the gap between metabolic modelling and a single-cell
experimental analysis. We developed a computational model
that integrates existing knowledge frommetabolic engineering
(Beard 2005; Korzeniewski and Brown, 1998) with our
recently established, ordinary differential equations (ODEs)
based model of the mitochondrial apoptosis pathway (Rehm
et al, 2006; Huber et al, 2007).
Our approach and findings are summarised by the chart
shown in Figure 1. Challenging the model with single-
cell experiments, we remodelled the kinetics of mitochondrial
depolarisation after cyt-c release in the presence or absence
of caspase activation. Mathematical modelling and experi-
mental validation identified glycolysis and variations in
the amount of cyt-c that remains accessible for respiration at
the mitochondria to be the key factors in determining
the ability of cancer cells to prevent a bioenergetic crisis
post-cyt-c release.
Results
Model calibration to in vitro data for ATP-
producing and non-ATP-producing mitochondria
We devised our model with gradually increasing complexity
and thus started with the widely studied experimental system
of isolated mitochondria. We assembled the network of
electrochemical reactions consisting of mitochondrial respira-
tion, ATP production and ion transport, and used a fixed
NADH/NAD disequilibrium as model input (Figure 2, and
Materials andmethods section). ByMonte-Carlo screening, we
calibrated the model into three scenarios that have been
experimentally well described. These were (i) ATP producing
(‘state-3’) mitochondria in buffered medium of an ATP/ADP
ratio of 3:1 (75% ATP, 25% ADP), (ii) non-ATP producing,
resting-state (‘state-4’) mitochondria (100%ATP, no ADP) and
(iii) a situation where we considered mitochondria to change
from state-3 to state-4 (Supplementary Figure 1A). Further
details on the model construction and its calibration can be
found in Supplementary Text I.
Our best fit led to a respiratory control ratio (state-3/state-4
respiration ratio) of 6.5:1, which is in agreement with reported
values of 5–10 (Nicholls, 1974a, b; Nicholls and Ward, 2000).
DCm values were calculated to be 157mV for state-4 and
137mV for state-3, consistent with literature values of DCm
from 140 to 150mV (Nicholls and Budd, 2000) and with
a reported 10–15% increase in DCm polarisation when
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Figure 1 Organisation scheme of the combined single-cell microscopy and in silico analysis. The scheme shows a workflow diagram of the procedure that was pursued
as outlined in the main text. Results of in silico modelling are shown in blue boxes. Red boxes indicate experimental validations as performed by single-cell microscopy or
by data obtained from the literature on isolated mitochondria. Green boxes depict research findings that were identified within the text and which resulted from
challenging the in silico predictions with experimental data and vice versa.
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mitochondria switch from state-3 to state-4 on ATP replenish-
ment (Nicholls, 1974). Transmembrane DpH between the
mitochondrial matrix and the mitochondrial IMS was calcu-
lated as 0.41 for state-3 and 0.32 for state-4 (Supplementary
Figure 1B). In the case where we modelled state-3 to state-4
transitions, we achieved ATP replenishment within 2min in
accordance with the well-established rapid kinetics of ATP
production, where a 90% equilibrium was reached in
about 1min (Pfaff et al, 1969; Supplementary Figure 1C for
ATP/ADP ratio 1D for respiration flux and DCm, 1E for ATP
synthase proton flux and activity of constitutive proton leaks
over time). A detailed sensitivity analysis of the influence
of model parameters (Supplementary Table VII) on calibration
results is given in Supplementary Figure 2. A parameter
cluster analysis (Gutenkunst et al, 2007) allowed to character-
ise the model mechanistic and identified four principal
components that explain 94% of the model parameter
variations (Supplementary Figure 3). Further details on the
model mechanistic and sensitivity analysis can be found in
Supplementary Text II.
Cyt-c release impairs respiratory flux and leads to
mitochondrial depolarisation
Mitochondrial cyt-c release followingMOMP is considered as a
point of no return in the mitochondrial apoptosis pathway.
Loss of cyt-c disrupts the mitochondrial electron transport
chain between complex III and IV, depolarises DCm and
impairs ATP production. Once in the cytosol, cyt-c leads to
activation of the apoptosome-dependent cell death pathway
and caspase-3 activation (Green and Kroemer, 2004). How-
ever, evidence has been presented that mitochondria and
cellular bioenergetics can recover after the release of cyt-c,
particularly when effector caspase activation is impaired
(Waterhouse et al, 2001; Dussmann et al, 2003a; Colell
et al, 2007). These studies suggested that cells can survive a
MOMP-dependent energy crisis subsequent to cyt-c release.
We used the model to investigate the effect of cyt-c release
on respiration and DCm in the presence or absence of active
caspases. Cyt-c release was modelled to start at time t¼10min
after assuming cells in equilibrium. The kinetic parameters of
cyt-c release were extracted from previous single-cell measure-
ments (see Materials and methods section; Goldstein et al,
2000; Luetjens et al, 2001; Waterhouse et al, 2001; Dussmann
et al, 2003a, Figure 3A, dotted green line). We assumed re-
equilibration of cyt-c between the IMS and the cytosol, and
therefore concluded that a final cyt-c fraction of 0.1%
remained accessible for respiration (see Method section).
We have hitherto denoted this cyt-c fraction as ‘respiration-
accessible cyt-c’.
We further modelled cyt-c to induce apoptosome formation
and to activate caspase-3 after release. Therefore, we included
our previously established model of mitochondrial apop-
tosis (Rehm et al, 2006) as a code subroutine and calculated
the level of active caspase-3 over time. The model predicted
caspase-3 activation and deactivation of complex I/II as
previously reported (Ricci et al, 2003; Figure 3A, solid
back and blue dashed lines, respectively) within 10–15min
of cyt-c release.
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Figure 2 Computational model of mitochondrial bioenergetics during cyt-c release and apoptosis. Interactions and transport processes between the mitochondrial
matrix (‘Matrix’), mitochondrial intermembrane space (‘IMS’) and the cytosol (‘Cytosol’). Roman numbers indicate single-cell processes that influence mitochondrial
bioenergetics: (I) model of mitochondrial apoptosis (according to Rehm et al, 2006) that activates caspase-3 upon cyt-c release; (II) cytosolic ATP production and
consumption; (III) active caspase-3 cleaving complex I/II; (IV) cyt-c release. Metabolite and ion fluxes of mitochondrial bioenergetics are given by Arabic numbers:
(1) input function (NADH/NAD disequilibrium¼45.8:1); (2–4) respiration complexes I/II (considered together), III and IV; (5) ATP synthase; (6) adenosine nucleotide
transferase (ANT); (7) mitochondrial inner membrane proton leaks; (8) passive transport of adenosine phosphates and anorganic phosphate trough the outer
mitochondrial membrane; (9) phosphate–proton cotransport and (10) proton–potassium antiport.
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As another consequence of cyt-c release, respiratory flux
was decreased after onset of cyt-c release to 5% within 10–
15min, while a further decrease to 1% was observed when
caspase-3 was active (see Supplementary Figure 4A for a
mechanistic scheme and 4B for results). Depolarisation to a
remnant DCm of88 or76mVwas evident in the absence or
presence of active caspase-3, respectively (Figure 3B). DCm
depolarisation after cyt-c release and further depolarisation
by active caspase-3 were robust over a wide range of model
parameter variations (see Supplementary Figure 5 and
Supplementary Text II for a sensitivity analysis).
To validate the kinetics of DCm depolarisation and the effect
of active caspase-3 in cellulo, we performed single-cell imaging
experiments using HeLa cells expressing cyt-c–green fluores-
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Figure 3 Live cell imaging and computational modelling of cyt-c release and mitochondrial depolarisation in HeLa cells expressing cyt-c–GFP. (A) Remodelling of
experimentally observed cyt-c release at time point t¼10 min (Goldstein et al, 2000; Waterhouse et al, 2001; Dussmann et al, 2003a) with a half-time of 1.5 min and a
remnant value of 0.1% (green dotted line), as described in the text, leads to active caspase-3 (black solid line) and deactivation of complex I/II (according to the model of
Rehm et al, 2006) within 15–20 min after onset of cyt-c release (blue dashed line). (B) Calculated depolarisation of mitochondrial membrane potential as a consequence
of cyt-c release as given in (A) with or without caspase-3-induced complex I/II cleavage (dashed red and solid blue line). (C,D) Representative single-cell traces of HeLa
cells expressing cyt-c–GFP incubated with 30 nM TMRM and exposed to 3 mM staurosporine (STS). (C) Traces of cyt-c release as indicated by the decrease in the s.d.
of average GFP pixel intensity and mitochondrial depolarisation measured by the average pixel intensity of TMRM (both normalised to initial values) of the two labelled
cells in (E). (E) Fluorescence images of cyt-c–GFP release followed by TMRM depletion, which indicates depolarisation of DCm. Residual TMRM staining is lost after
addition of FCCP. Scale bar, 10 mm. (D, F) As in (C, E), but in the presence of 100mM of the caspase inhibitor zVAD-fmk administrated 1 h prior to exposure to 3mM
STS. Source data is available for this figure at www.nature.com/msb.
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cent protein (GFP), which we incubated with 30nM tetra-
methyl rhodamine methyl-ester (TMRM). Cyt-c release was
induced with 3 mM of the broad-spectrum kinase-inhibitor
staurosporine (STS). Indeed, these experiments suggested
a greater degree of mitochondrial depolarisation in the
absence of a broad-spectrum caspase-inhibitor Z-Val-Ala-Asp
(O-methyl)-fluoromethylketone (zVAD-fmk; Figure 3C and E)
than in its presence (Figure 3D and F). This indicates a role of
caspase-3 in DCm depolarisation after cyt-c release, although
the influence of changes in plasma membrane potential on
TMRM redistribution upon caspase activation cannot be
excluded (Dussmann et al, 2003a).
In summary, the single-cell model mechanistically described
and quantified DCm depolarisation as measured in living
cells subsequent to cyt-c release. Moreover, it suggested that
an additional complex I/II cleavage may further impair
respiration and DCm.
Characterisation of ATP synthase reversal as a
stabiliser of DWm
Maintenance of DCm subsequent to cyt-c release is essential
for ionic homeostasis within the cell and thus may prevent the
onset of necrotic cell death (Nicholls, 1977; Nicholls and Budd,
2000). Reversal of ATP synthase has been proposed to stabilise
DCm by pumping protons from the matrix into the IMS, while
consuming instead of generating ATP (Goldstein et al, 2000;
Chinopoulos and Adam-Vizi, 2009). However, it has also been
reported that DCm can stabilise in the absence of ATP synthase
reversal. We therefore aimed to investigate whether and under
what conditions ATP synthase reversal was present and if so
what the implications on cytosolic ATPandDCmwere.We first
confirmed that ATP synthase activity was reversed 10min after
onset of cyt-c release when respiration-accessible cyt-c
decreased to 0.1% in our model (Figure 4A, blue solid line).
This was slightly more pronounced when caspase-3 deactiva-
tion of complex I/II was also taken into consideration
(Figure 4A, red dashed line). Moreover, our model confirmed
that ATP synthase reversal consumed ATP (Supplementary
Figure 6A), that glycolysis prevented ATP depletion during this
reversal (Supplementary Figure 6B) and that ATP synthase
reversal was robust when model parameters (Supplementary
Table VII) were increased or decreased over a fivefold
parameter range (Supplementary Figure 7A and Supplemen-
tary Text II).
We then examined whether ATP synthase reversal stabilised
DCm, as was previously suggested (Rego et al, 2001;
Dussmann et al, 2003a). We therefore set ATP synthase
activity to zero in our single-cell model at 30min after onset of
cyt-c release. Inhibition of the reversed ATP synthase (as in
Figure 4A) predicted the occurrence of a further mitochondrial
depolarisation from 88 to 65mV (76 to 26mV when
considering complex I/II inhibition by caspase-3, Figure 4B).
Owing to the lower DCm and a resulting lower electrostatic
barrier for proton pumping through respiratory complexes, a
slight regain of respiratory flux (Supplementary Figure 6C)
was also detected.
To experimentally validate the presence of reversed ATP
synthase, we added 5mM of the ATP synthase inhibitor
oligomycin to HeLa cyt-c–GFP cells subsequent to cyt-c release.
Indeed, oligomycin induced a further DCm depolarisation
within 30min (Figure 4C and D) indicating reverse ATP
synthase activity, albeit in only 20% of a total of 237 cells
(n¼6 experiments). Overall, 65% of cells showed no detect-
able reaction. Strikingly, about 15% even showed a partial
repolarisation immediately after administration of oligo-
mycin (Figure 4E) suggesting that ATP synthase was main-
tained in forward mode in these cells. In all cells, the
protonophore carbonyl cyanide-p-trifluoromethoxyphenylhy-
drazone (FCCP) could fully depolarise DCm to negligible
levels, demonstrating that mitochondria maintained a remnant
DCm. In conclusion, ATP synthase reversal was found in some
cells to stabiliseDCmby consumingATPafter cyt-c release, yet an
unexpectedly wide cell-to-cell heterogeneity was observed with
regard to the direction of ATP synthase activity.
Respiration-accessible cyt-c subsequent to MOMP
influences activity and direction of ATP synthase
To explain this experimentally detected cell-to-cell hetero-
geneity in ATP synthase activity and direction, we modelled
that individual cells within a population have heterogeneous
levels of respiration-accessible cyt-c subsequent to cyt-c
release. As an example, cells may differ by the volume fraction
of mitochondria per cell, which leads to varying amounts
of cyt-c staying in the vicinity of the respiratory chain after
re-equilibration between IMS and cytosol. Model results
suggested that cells with respiration-accessible cyt-c levels
o0.7% of the initial concentration showed reversed activity
(Figure 4F, marked as ‘reverse’), whereas those that retained
1.2% or higher of their original cyt-c level maintained ATP
synthase activity in ATP forward mode (Figure 4F, marked as
‘forward’). The fraction of cells with levels of accessible cyt-c
between 0.7 and 1.2% were calculated to have no significant
ATP synthase activity (Figure 4F, marked as ‘No act’).
Availability of bioenergetic substrates determines
ATP synthase activity and direction subsequent to
MOMP
The above modelling results suggested that the levels of
respiration-accessible cyt-c after release influence the direction
of the ATP synthase. Themodel further would suggest that ATP
synthase directionality is linked to glycolysis, as reverse ATP
synthase consumes glycolytically produced ATP (Supplemen-
tary Figure 6A and B). Therefore, we next studied the
dynamics of ATP synthase activity and DCm in the absence
of glycolysis. To this end, we performed single-cell imaging
experiments on HeLa cells exposed to 3 mMSTS andmeasured
cyt-c–GFP and DCm in the absence of glucose, but in the
presence of sodium pyruvate as a substrate for the mitochon-
drial TCA. Cells were treated with oligomycin subsequent to
MOMP to evaluate in which direction ATP synthase was
working. Under these conditions, we observed that oligomycin
led to a repolarisation of DCm in 49 out of 67 cells. This
indicated that ATP synthase was maintained in forward mode
in the majority of cells (n¼3 experiments; see Figure 5A for
single-cell kinetics, Figure 5B for images). On average,B12%
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Figure 5 DCm Dynamics induced by oligomycin after release of cyt-c are glucose dependent. (A, B) HeLa cells expressing cyt-c–GFP were incubated with 30 nM
TMRM, 2 mM sodium pyruvate in medium without glucose and 100 mM zVAD-fmk 1 h prior to the addition of 3mM STS. Five mM oligomycin was added after cyt-c
release, followed by the addition of 10 mM FCCP 30 min later, as indicated by the white and black arrows, respectively. Single-cell traces and time-lapse images are
representative for 49 out of 67 cells in n¼3 experiments. (A) Single-cell kinetics of two representative cells. Diamonds show data from the cell shown in (B). (B)
Representative fluorescent images associated with (A). Scale bar, 10 mm. (C) Difference between the average fluorescent intensity in TMRM before and after 5mM
oligomycin addition in cell populations cultured with or without glucose. Oligomycin was added at least 15 min after onset of cyt-c–GFP release. While ATP synthase
reversal was prominently present for cells in medium containing 5.5 mM D-glucose as indicated by the decrease in TMRM fluorescence, the cells depleted of D-glucose
showed an increase in the TMRM average pixel intensity, indicating a slight repolarisation (difference between bars is significant, independent samples t-test, variances
not equal, Po0.05). (D) Modelling of ATP synthase activity dependent on time and respiration-accessible cyt-c in cells equivalent to Figure 4f, but without glycolysis. The
ATP synthase reversal only briefly occurs until the cellular ATP reservoir is depleted. The ATP synthase can still produce ATP when the respiration-accessible cyt-c is
41% of its initial value and if the mitochondrial energy metabolism has enough substrate (e.g., through TCA cycle, sodium pyruvate). Source data is available for this
figure at www.nature.com/msb.
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increase in TMRM signal was detected in the absence of
glucose after treatment with oligomycin, whereas cells in
5.5mM glucose media, in contrast, showed a decrease of
B17% in the signal (Figure 5C). Setting glycolytic ATP
production to zero (Jprod ¼0) while maintaining cytosolic
ATP consumption (Jcons¼xATPC *ATP, Equation (1)), the
model indeed confirmed that cells in pyruvate medium
maintain ATP synthase in forward mode (Figure 5D). Under
the assumption of the same cell-to-cell variability in respira-
tion-accessible cyt-c after release as for cells in glucose
medium (0–2% of initial cyt-c), reversal was calculated to
occur only transiently between t¼20–40min and to occur only
in cells with 0.2% or less cyt-c remaining accessible for
respiration (Figure 5D versus Figure 4F). Consequently, cell
populations in low or no glucose media can be expected to
show a tendency to either maintain forward or to cease ATP
synthase activity after cyt-c release rather than maintaining
stable ATP synthase reversal.
High glucose induces repolarisation of DWm in
HeLa cells with inhibited caspases subsequent
to cyt-c release
An important conclusion from our modelling above was that
glycolytic ATP production determines the dynamics of ATP
synthase and thereby influences post-release bioenergetics in
HeLa cells. Indeed, the switch from mitochondrial to cytosolic
ATP production is a hallmark of cancerogenesis (Vander
Heiden et al, 2009). To further explore this mechanistically,
we modelled cells after cyt-c release assuming that glycolysis
maintained cellular ATPat varying levels from480%.We first
considered a scenario with 0.1% respiration-accessible cyt-c
and synthase reversal. In this study, the model predicted that
subsequent to cyt-c release, an elevation of cytosolic ATP levels
through increased glycolysis would increase ATP synthase
reversal, leading to a higher proton efflux from the matrix
and in this way partially restores DCm (Figure 6A). When
assuming 5% respiration-accessible cyt-c after release, where
ATP synthase operates in forward mode, an elevation of
cytosolic ATP from 80–100% led to a partial decrease in ATP
synthase in forward activity, leading to a lower proton influx
into thematrix and also to a repolarisation ofDCm (Figure 6B).
Thus, we concluded that in both scenarios ATP increase can
repolarise DCm either by increasing ATP synthase reversal or
decreasing its forward activity. Sensitivity analysis proved
both recovery mechanisms stable over a broad range of
model parameter variations (Supplementary Figure 7C, D and
Supplementary Text II).
To validate these model predictions experimentally, we
treated HeLa–cyt-c–GFP cells with high extracellular glucose
post-cyt-c–GFP release. Using a glucose-FRET single-cell
reporter (Takanaga et al, 2008), we confirmed that cytosolic
levels of glucose increased when extracellular glucose was
elevated from 5.5 to 25mM, indicating a higher glucose uptake
(Supplementary Figure 8A). Likewise, we detected a higher
lactate production in STS-exposed HeLa cells exposed to
25mM compared with 5.5mM, demonstrating that the
enhanced glucose uptake resulted in increased glucose
utilisation (Supplementary Figure 8B).
We next investigated whether elevated glucose was capable
of stabilising DCm subsequent to cyt-c release. At first, we
incubated HeLa–cyt-c–GFP cells in 25mM high glucose media
for 1 h and subsequently induced cyt-c release with 3mM
STS in the presence of 100 mM zVAD-fmk. The remnant DCm
detected subsequent to cyt-c release was significantly higher in
cells incubated with 25mM glucose than in such with 5.5mM
glucose or glucose-free medium (Supplementary Figure 8C).
To investigate whether elevated glucose led to stabilisation of
DCm even when added subsequent to cyt-c release, we
maintained HeLa–cyt-c–GFP cells in medium supplemented
with sodium pyruvate in the absence of glucose and in the
presence of zVAD-fmk, and induced apoptosis with 3 mM STS.
After cyt-c release, we increased the glucose concentration
from 0 to 25mM in the extracellular medium and monitored
the effect of this on DCm. Strikingly, we observed a significant
increase in TMRM fluorescence intensity from 18.6±1.6 to
46.9±1.4 (% relative to a value of 100% before cyt-c release)
averaged over 196 cells from three independent experiments
(Figure 6C and E), indicating a partial DCm repolarisation.
A similar level of repolarisation was also detected in HeLa
cells that were not transfected with cyt-c GFP (Supplementary
Figure 9).
We finally tested the hypothesis that the above recovery
mechanism is particularly prominent in cancer cells when
compared with non-transformed cells. MCF-7 breast cancer
cells expressing cyt-c–GFP (Luetjens et al, 2001) and treated
with STS to induce apoptosis showed a quantitatively similar
response as HeLa cells subsequent to cyt-c release. Addition of
25mM glucose to an originally glucose-free, sodium pyruvate-
containing medium led to a significant (Po0.05) B2.5-fold
increase of TMRM average pixel intensity from 19.7±1.4%
Figure 6 Glycolysis stabilises DCm subsequent to cyt-c release in the absence of active caspases. (A) Modelled DCm repolarisation via higher glycolytic ATP and
increased ATP synthase reversal. Cells were assumed to retain 0.1% respiration-accessible cyt-c after release (which was associated with ATP synthase reversal) and
different cytosolic ATP levels were considered to be established by glycolysis (calculations for ATP between 80–99%). Elevated cytosolic ATP led to higher
ATP synthase reversal (left panel) causingDCm increase (right panel) over almost the entire range. (B)DCm Repolarisation via higher glycolytic ATP and reduced ATP
consumption. Model is presented as in Figure 6a, yet retaining 5% respiration-accessible cyt-c to preserve forward ATP synthase activity after cyt-c release. ATP derived
from increased glycolysis led to a reduction in ATP synthase activity (left panel) until it has ceased and thus resulted in less proton influx into the mitochondrial matrix
(left panel). As a consequence, decreased proton consumption by ATP synthesis resulted in a partial DCm repolarisation. (C–E) HeLa cyt-c–GFP cells incubated with
2 mM sodium pyruvate in the absence of glucose and exposed to STS in the presence of zVAD-fmk. Following cyt-c-induced mitochondrial depolarisation, 25 mM
glucose was added to the medium. (C) Representative traces of a cell with cyt-c–GFP release and recovery of DCm measured by TMRM. (D) Comparison of the
average TMRM fluorescence in cell populations subsequent to cyt-c release before and 30 min after addition of 25 mM glucose to medium without glucose supply. The
significantly higher TMRM fluorescence in the latter scenario indicates a partial DCm repolarisation (196 cells out of three experiments). (E) Cyt-c–GFP and TMRM
fluorescence as well as DIC channel images during depolarisation and recovery for a typical cell. Scale bar, 10 mm. Source data is available for this figure at
www.nature.com/msb.
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after cyt-c release to 47.7±2.6% after glucose addition
(n¼167 cells). In contrast, non-transformed human epithelial
CRL-1807 cells expressing cyt-c–GFP did not show a signifi-
cant repolarisation after cyt-c release (7.0±1.6 to 10.7±2.4%,
N¼21 cells) when culture mediumwas changed from pyruvate to
25mM glucose (see Supplementary Figure 10A, B for a typical cell
response), suggesting that cancer cells are preferentially capable of
undergoing glucose-induced recovery of DCm.
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Discussion
Systems model of bioenergetic consequences
of cyt-c release
Understanding the mechanistic details of how cancer cells are
able to resist apoptotic and metabolic consequences of ther-
apeutically induced cyt-c release can provide strategies to
increase treatment efficiency and reduce clinical relapse. While
cancer cells are able to evade apoptosis by impairing caspase
activity by loss-of-function mutations or increased expression of
their antagonists, the mechanisms by which they can survive
energy crisis after metabolic impairment is a matter of extensive
current research (Vander Heiden et al, 2009).
Combining computational modelling with single-cell micro-
scopy, we provided the first systems study of cellular bioenergetics
subsequent to cyt-c release. We integrated approaches from
metabolic engineering (Beard, 2005; Beard and Qian, 2007; Dash
and Beard, 2008) and apoptosis signalling (Rehm et al, 2006;
Huber et al, 2007), gradually increased model complexity, and
eventually used it as a predictive tool. To this end, we remodelled
bioenergetic state variables in isolated mitochondria, described
DCm depolarisation subsequent to cyt-c release in the presence or
absence of effector caspases, and characterised ATP synthase
reversal as a consumer of cytosolic ATP and a stabiliser of DCm.
We identified a cell-to-cell heterogeneity in the ATP syn-
thase direction subsequent to cyt-c release, which the model
explainedbyvariations in the amount of respiration-accessible cyt-
c and the cell’s glycolytic capacity. Finally, our model demon-
strated that an increase in cytosolic ATP production as a
consequence of higher glucose levels can repolarise DCm in an
ATP synthase-dependentmanner and independent of its direction.
By incorporating data on cyt-c release kinetics from previous
single-cell studies, the model was first able to correctly capture
the kinetics of DCm depolarisation observed in previous
single-cell experiments in HeLa cells (Waterhouse et al, 2001),
MCF7 breast cancer cells (Dussmann et al, 2003a), DU145
prostate cancer cells (Dussmann et al, 2010), and primary
neurons (Nicholls and Ward, 2000). Furthermore, the model
allowed to quantify the impairment of respiration and DCm
values before and during release as well as the feedback of active
caspases to DCm (Ricci et al, 2003). As experimental techniques
to quantify respiration and in situmitochondrial ATP production
in a single cell are still under development (Zhdanov et al, 2008;
Imamura et al, 2009), systems modelling can complement
existing experimental techniques to quantitatively predict
cause–effect relationships and validate the plausibility of
experimental results (Bentele et al, 2004; Rehm, et al, 2006;
Albeck et al, 2008; Lavrik, 2010).
ATP synthase direction after cyt-c release depends
on accessible cyt-c and the cell’s glycolytic
capacity and exhibits a wide heterogeneity within
a cell population
It was suggested previously that freely diffusing cyt-c into and
out of the IMSmay critically determineDCm subsequent to cyt-
c release. We modelled that a cyt-c fraction remains accessible
for respiration subsequent to release (‘respiration-accessible
cyt-c’). Our model suggested that small variations in such
levels significantly account for the experimentally detected
population heterogeneity in the direction and amount of ATP
synthase proton flux. Variations in respiration-accessible cyt-c
may arise from incomplete mitochondrial release. Such
incomplete release has been associated with failure of cristae
remodelling in the absence of the BH3-only family member
BID or the intramitochondrial protein OPA1 (Scorrano et al,
2002; Frezza et al, 2006). Even when re-equilibration between
the mitochondrial IMS and the cytosol is assumed to be
complete, different amounts of volume fractions of mitochon-
dria in a cell may result in different cytosolic cyt-c levels after
cyt-c release.
The amount of ATP produced by glycolysis was found to
be another key determinant for ATP synthase direction
subsequent to cyt-c release. Cell populations with a reduced
capability to produce ATP by glycolysis were predicted to show
a tendency to maintain forward or to show no ATP synthase
activity, rather than reversal of ATP synthase activity. Indeed,
in cells cultured in pyruvate instead of glucose, which were
therefore unable to produce ATP by glycolysis, ATP synthase
reversal was barely detected. We summarise the influence of
respiration-accessible cyt-c and the cell’s glycolytic capacity to
determine ATP synthase direction within a cell population
subsequent to cyt-c release in the state-space diagram in
Figure 7A. Typically, individual cells of a population have a
large heterogeneity in ATP synthase direction (grey boxes)
with one group showing ATP synthase reversal (indicated by
‘1’), another one having ATP synthase in forward mode (‘2’),
while others do not show any detectable ATP synthase activity
(cells close to the dashed line). Cells in a mediumwith sodium
pyruvate, but lacking glucose, are not able to produce ATP by
glycolysis and therefore cannot meet the ATP demand needed
for mitochondria to maintain stable ATP synthase reversal. All
ATP that was produced before cyt-c release will be eventually
used up and ATP synthase will cease or switch back to forward
mode. On a population level, less and less cells will be found
with reverse ATP synthase as ATP depletes (direction indicated
by the black arrow).
Increased glucose utilisation leads to partial DWm
repolarisation
Green and colleagues (Waterhouse et al, 2001) speculated that a
sufficiently high cyt-c concentration in the vicinity of mitochon-
dria may lead to repolarisation of DCm and in this way may
contribute to a cellular recovery from bioenergetic crisis. Our
model indeed suggested that such a recovery is possible, but
requires an activemechanism, in our case an increase in cytosolic
ATP production by elevated rate of glycolysis.
The proposed mechanism is summarised in Figure 7B. For
cells that have ATP synthase working in reverse mode after
release (indicated by ‘1’, as in Figure 7A), elevated ATP
production after glucose addition leads to increased proton
efflux from the matrix and thus partially repolarise DCm.
Likewise, cell populations that can maintain ATP synthase in
forward mode in low-glucose medium (denoted by ‘2’) also
increase DCm upon glucose addition.
By exposure of HeLa cells to high extracellular glucose
levels, we were able to increase glucose uptake and its
utilisation consistent with previous studies in HeLa and INS-1E
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cells (Li et al, 2009; Rodriguez-Enriquez et al, 2009). We
confirmed that high glucose was able to stabilise (cells
maintained in high-glucose media) and/or to repolarise (cells
where glucose was added subsequent to release) DCm
consistent with above model predictions. While we confirmed
this stabilisation and recovery also in MCF7 breast cancer
cells, no significant effect of elevated glucose was found in
non-transformed CRL-1807 cells. In conjunction with an
impairment of caspase-dependent cell death observed in many
human cancers, this mechanismmay provide cancer cells with
a competitive advantage to evade cell death induced by
anticancer drugs or other stress conditions when compared
with non-transformed cells.
How do cancer cells achieve an increase in glucose uptake
and utilisation? Interestingly, it has been demonstrated that
mitochondrial impairment and hypoxia transcriptionally
elevate glucose transporter isoform GLUT1 levels (Ebert
et al, 1995) in HeLa cells arguing also for a medium-term
adaptation to stress situations. Elstrom et al (2004) have
shown that LN5.12 murine prolymphocytic cells increase their
glycolytic rate to stabilise DCm when the prosurvival serine/
threonine kinase AKT was induced (Elstrom et al, 2004).
The same group also reported that AKT overexpression
maintains a physiological DCm under growth factor with-
drawal (Plas et al, 2001). Other studies reported that HeLa cells
increase their turnover of the glycolytic machinery through
upregulation of the rate-limiting glycolytic enzymes GAPDH
and phosphofructokinase (PFK1) (Chesney et al, 1999; Colell
et al, 2007), or switch between OXPHOS and glycolysis upon
growth medium changes (Rossignol et al, 2004).
While this study has focused on the consequences of cyt-c
release on mitochondrial bioenergetics, our model can also
be exploited to study the dependency of caspase activity on
cytosolic pH (Matsuyama et al, 2000) and to investigate
the influence of ATP levels on apoptosome formation and
mitochondrial apoptosis (Zou et al, 2003). Likewise, it can be
extended to include detailed mechanistic on glycolysis, the
TCA cycle (Wu et al, 2007), autophagy, or production of
reactive oxygen species (Atlante et al, 2000). As novel cancer
therapeutics address multiple targets in apoptotic as well as
metabolic pathways (Lessene et al, 2008), such cross-talk
models may become an essential tool for in silico prediction of
their therapeutic effectiveness both in terms of triggering
programmed cell death and in overcoming bioenergetic rescue
mechanisms.
Materials and methods
Cell culture and transfection
Generation and characterisation of human HeLa D98 cervical
carcinoma cells or MCF7 breast cancer cells stably expressing a
cyt-c–GFP fusion protein have been described (Dussmann et al,
2003a). Non-transformed CRL-1807 cells were obtained from the
ATCC. HeLa cells were cultivated in RPMI, and CRL-1807 cells were
grown in DMEM at 371C in a humidified atmosphere at 5% CO2. Both
media contained 10% fetal bovine serum (FBS). CRL-1807 cells were
transfected with 1-mg plasmid DNA encoding for cyt-c–GFP, as
described (Luetjens et al, 2001), and 3 ml/ml Lipofectamine 2000
(Invitrogen, Biosciences, Dublin, Ireland) and grown for 2 days prior to
the experiment. We have previously shown that cyt-c–GFP is imported
intomitochondria and coreleasedwith endogenous cyt-c after selective
outer membrane permeabilisation with digitonin (Luetjens et al,
2001). Concomitant release of endogenous cyt-c and cyt-c–GFP from
mitochondria during apoptosis has also been demonstrated in other
reports (Goldstein et al, 2000; Munoz-Pinedo et al, 2006). Cell culture
ingredients were obtained from Sigma-Aldrich, Dublin, Ireland.
Live cell imaging
Cyt-c–GFP release was monitored by time-lapse confocal microscopy,
and mitochondrial membrane potential (DCm) was simultaneously
determined by the distribution of the monovalent cationic dye TMRM
(MobiTec, Go¨ttingen, Germany) using an inverted confocal laser
scanning microscope (Fluoview 200, Olympus, Hamburg, Germany),
as described previously (Dussmann et al, 2003a; Rehm et al, 2003).
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Figure 7 ATP synthase activity and DCm recovery in cell populations subsequent to cyt-c release. (A) ATP synthase direction in dependence on respiration-
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the matrix, thereby partially repolarising DCm. Cell populations with ATP synthase in forward mode (denoted by ‘2’) achieve a similar partial DCm repolarisation through
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Alternatively, confocal microscopes equipped with a 488nm
argon laser and a 543nm HeNe Laser, a 488/543 dichroic beam
splitter, and a 631.4 NA oil immersion objective (LSM 510 and 710,
Carl Zeiss, Jena, Germany) were used. On the LSM 510, fluorescence
emissionwas split with a 540nm secondary beam splitter and detected
after transmitting a 505–550 nm band-pass filter for GFP or a 560nm
long-pass emission filter for TMRM. On the LSM 710, the emission
beam path was adjusted so that GFP was detected in the range of
495–550 nm and TMRM in the range of 565–750 nm. Fluorescence
was detected from a 1-mm thick confocal section (full width
half maximum). For time-lapse imaging, culture dishes were
mounted onto the microscope stage that was equipped with a mini
incubator and objective heater (Pecon, Erbach, Germany). In control
experiments, constant fluorescence values for cyt-c–GFPand TMRMas
well as a constant rate of cell divisions were detected over a period of
24 h. For induction of apoptosis, cells were incubated with 3-mM STS
(Axxora, Alpha Technologies, Blessington, Ireland) on the stage after
1 h of equilibration with 30 nM TMRM. Caspase activation was
inhibited by 1 h preincubation with 100mM zVAD-fmk (Bachem,
Heidelberg, Germany). During the measurements, cells were treated
with oligomycin and FCCP (all from Sigma-Aldrich, Dublin, Ireland)
as indicated. Where required, glucose-free RPMI medium was
enriched with 10% FBS, 15mM HEPES (pH 7.4), and 2mM sodium
pyruvate. D-Glucose was added at concentrations of 5.5 or 25mM
added during time-lapse imaging at times as indicated. In order to
investigate the effect of enhanced glucose availability after MOMP,
glucose was added when at least 75% of cells had released cyt-c–GFP.
In order to prevent evaporation, the media was covered with
embryo-tested paraffin oil. Images were analysed using Metamorph
image processing software (Metamorph 7.1–7.6, Molecular Devices,
Wokingham, UK). The distribution of cyt-c–GFP was calculated
using the s.d. of the average pixel intensity as described previously
(Dussmann et al, 2003a), and decreases in the s.d. value indicate the
redistribution of GFP from punctuate (mitochondrial) to homo-
geneous (cytoplasm and nucleus) patterns. The average pixel
intensity of the TMRM signal represents the mitochondrial membrane
potential as described previously (Ward et al, 2000). Cells from
three to six separate experiments per condition were analysed, and
parameters were compared using Student’s t-test for paired samples or
independent samples with Po0.05 considered to be significant (SPSS
15, LEAD Technologies, Chicago, USA).
Imaging of intracellular glucose concentration
HeLa cells were transfected with IMS–RFP, a sensor of MOMP,
(Albeck et al, 2008) and a glucose-sensitive CFP-Citrine FRET probe
FLII12Pglu-700uDelta6 (Takanaga et al, 2008, Addgene plasmid
17866), and were used for time-lapse imaging on the LSM510 Meta
confocal microscope. IMS–RFP release was observed with settings as
used for TMRM. The 405 laser and the 405/514 multichroic beam
splitter was used for CFP excitation, CFP emission and FRET channel
were measured using the 470–500nm band-pass filter and the
505–550 nm band-pass filter, respectively, separated by a secondary
dichroic beam splitter at 515 nm. Citrine fluorescence was detected
from optical slices of 3mm thickness at settings used for GFP. FRET/
CFP ratio images were following background subtraction, and an
increase in average pixel intensity indicated an increase in the
intracellular glucose concentration. Acceptor photobleaching was
negligible at the acquisition settings used. Image processing was
performed using MetaMorph software as described above. Cells were
incubated with growth medium supplemented with 15mM HEPES,
2mM sodiumpyruvate, 30nMTMRM, 100 mMcaspase inhibitor zVAD-
fmk, and 5.5mM D-glucose. Release of IMS–RFP was induced by
addition of 3mM STS. A quantity of 20mM D-glucose was added at
times as indicated in the figures.
Lactate assay
HeLa cells cultured in 96-well plates were treated with STS and
zVAD-fmk as above in the presence of 0, 5.5 or 25mM D-glucose, as
indicated. After 8 h, extracellular media were removed and
stored at 801C. A 10ml sample was diluted 20-fold and assayed with
a Lactate Assay Fluorometric Kit (ab65330, Abcam plc, Cambridge,
UK), as per manufacturer’s protocol in a BIO TEK Synergy HT
fluorometer (Winooski, Vermont, USA). Fluorescence values were
calibrated to a standard curve generated using lactate standard
supplied with the kit.
Computational model of mitochondrial
bioenergetics
We established a model to study the temporal behaviour of the
bioenergetics state variablesDCm, ADP/ATP ratio, respiratory flux and
ATP synthase activity (Figure 2). We focused on flux through the
respiratory chain and ion transporters across the mitochondrial inner
membrane. Fluxes are specified by Arabic numbers and are described
here in sequential order. Respiration was driven by disequilibrium of
the NADH/NAD ratio (as is generated by the TCA cycle). Electro-
chemical flux through mitochondrial complexes I/II, III and IV in IMS,
ATP synthesis, adenine nucleotide translocase, constitutive proton
leaks, proton–phosphate cotransport, Kþ/proton-exchanger and ATP
transmembrane transport were adapted from the literature (Korze-
niewski and Brown, 1998; Korzeniewski and Zoladz, 2003; Beard,
2005; Beard and Qian, 2007; Dash and Beard, 2008). Unlike above
reports, we also calculated all state variables for non-equilibrium
states and as a function of time.
We calibrated this part of themodel to results obtained from isolated
mitochondria in different supporting media. These included a
‘buffered’ medium with a constant external ATP/ADP ratio of 3:1
(i.e., 25% ADP deficiency) to model mitochondria in ‘state-3’, a
mediumwith 100%ATPand 0%ADP to model mitochondria in ‘state-
4’, and one where an initial ATP deficiency of 25%was replenished by
mitochondrial ATP production to model a state-3 to state-4 ‘transition’.
As these scenarios have been extensively studied in the literature
(Nicholls and Ferguson, 1992; Nicholls and Budd, 2000; Ward et al,
2000; Kushnareva et al, 2002), we were able to fix unknown model
parameters (input NADH/NAD disequilibrium, complexes I–IV, ATP
synthase and ATP transferase rates of activity) by Monte-Carlo
screening to render the experimental situation (see Supplementary
Text 1 for methods and results).
Modelling of cytosolic ATP, cyt-c release and
caspase-mediated complex I/II deactivation
We extended the above calibrated model of mitochondrial bioener-
getics and included cytosolic processes, assuming a mitochondrial
volume fraction of 1% in the cell (Poppe et al, 2001). We first
implemented processes for cytosolic ATP turnover (ATP production
and consumption in the cytosol). Cytosolic ATP production was
modelled (flux Jprod, glycolysis) by increasing the ATP concentration
in proportional to the amount of available ADP (ADP-ATP,
JprodBADP). This was balanced by ATP-consuming processes
(flux Jcons), such as Na
þ/Kþ–ATPase activity and protein synthesis,
considered to be dependent on the level of available ATP (ATP-ADP,
JconsB ATP). Superposition of both effects led to a flux
JATPC ¼ Jprod  Jcons ¼ xATPC  ðKATDP  ADP  ATPÞ: ð1Þ
KATDP equals the cytosolic ATP/ADP ratio at equilibrium in a cell when
mitochondria are disregarded. It was set to 3 (ATP/ADP¼3:1, i.e., 75%
ATP; AMP neglected) to mimic cells under normal glucose and set to 0
for a pyruvate-only medium (consistent to Jprod¼0). To model variable
rates of glycolysis as in Figure 6, we directly fixed ATP and ADP.
Combining the cytosolic (Equation (1).) and mitochondrial ATP
production, we adapted the flux strength xATDP to 0.1980/s to yield
an equilibrium ATP/ADP ratio of 20:1 (95% ATP), as experimentally
observed in HeLa cells with intact mitochondria (Evans and
Kaplan, 1977).
Cyt-c release was modelled to start at the onset time trelease¼10min
after assuming cells in equilibrium. An exponential decay with half-
release time t1/2_cyt_c¼1.5min was remodelled from experiments
performed by our group and others (Goldstein et al, 2000; Luetjens
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et al, 2001; Waterhouse et al, 2001). This is equivalent to assuming
the fluxes
Jcytc tot;loss ¼ lnð2Þ=t1=2 cytc  ðcytcactualtot ðtÞ  cytcfinalÞ
Jcytc red;loss ¼ lnð2Þ=t1=2 cytc  ðcytcactualred ðtÞ  cytcfinalÞ; ð2Þ
which describe loss of total and reduced cyt-c (cytctot
actual, cytcred
actual) and
lead to a depletion of complex IV activity. We assumed a final cyt-c
concentration cyt-cfinal to be accessible for respiratory complexes after
the release. This reflected the fact that even under unimpaired
cyt-c release, the cyt-c concentration in the mitochondrial IMS does
not drop to zero, but re-equilibrates between IMS and cytosol.
Assuming the IMS as 10% of the mitochondrial volume and a volume
fraction of 1% mitochondria in a cell (Dussmann et al, 2003a),
complete cyt-c release was therefore considered to lead to a final
‘accessible’ cyt-c concentration that is 0.1% of its initial value.
A different ratio was used, when impaired cyt-c release was considered
(Figures 4F, 5D and 6B).
Caspase-3 has been reported to deactivate complex I and II of the
respiratory chain (Ricci et al, 2003). We modelled this deactivation by
the enzymatic reaction Qactiveþ casp3(t)-Qinactive. This assumes that
active complex Qactive gets cleaved to its inactive form Qinactive by
the amount of caspase-3 at a certain time t (casp3(t)), subsequent to
cyt-c release. This leads to the following loss-of-function fluxes.
JCasp Qtot ¼ kcasp 3  ðQactiveQtot  QfinalÞ  casp3ðtÞ
JCasp QH2 ¼ kcasp 3  ðQactiveQH2  QfinalÞ  casp3ðtÞ ð3Þ
which modelled a disruption of the electron transfer from complex I/II
to complex III.
Total ubiquinone fractions QQtot
active and reduced ubiquinone fractions
QQH2
active were treated independently as they represented separate
degrees of freedom. A remnant fraction that remains active (Qfinal)
was assumed as 1% of the initial ubiquinone concentration.
Furthermore, kcasp-3 described the caspase-3 enzymatic cleavage rate
(set to 12 mM/s; Stennicke et al, 2000)). The activation profile of free
active caspase-3 (casp3(t)) over time was calculated using a network
of ODEs, as described previously by our group (Rehm et al, 2006).
Briefly, concomitant cyt-c and Smac release subsequent to MOMP led
to apoptosome formation, which induced a cascade of caspase-9 and
caspase-3 activation.
Model code and data
The model was constructed by a system of ODEs that describe
temporal changes of metabolites, ions and biochemical parameters by
biochemical fluxes. Themodel codewas implemented inMATLAB (the
Mathworks, UK) and is given in the Supplementary Dataset I. Code use
is described in Supplementary Text I. State variables of the model are
given in Supplementary Table I. Variables to control the code for
different biological situations are given in Supplementary Table II. The
ODE system is depicted in Supplementary Table III. The biochemical
fluxes that are used to construct this ODE system are biologically
described in Supplementary Table IV and mathematically detailed in
Supplementary Table V. Biological constraints such as moiety
conservation are given in Supplementary Table VI. Model parameters
used in the study and discussed in the sensitivity analysis (Supple-
mentary Text II) are given in Supplementary Table VII, while physical
and chemical constants together with ion concentrations that are used
in the model are described in Supplementary Table VIII. Supplemen-
tary Table IX finally describes the reaction network used for calculating
caspase-3 activation over time.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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